Human CCL17/A-152E5.3/ABCD-2 ORF/cDNA clone-Lentivirus particle (NM_002987)
Cat. No.: vGMLP004761
Pre-made Human CCL17/A-152E5.3/ABCD-2 Lentiviral expression plasmid for CCL17 lentivirus packaging, CCL17 lentivirus production, overexpression stable cell line development, cell transient transfection and gene delivery targeting T/B/NK cells, macrophages, cardiomyocytes, hepatocytes, and neurons.
The GM Vector Core (GMVC) specializes in custom lentivirus development and offers a range of lentivirus manufacturing solutions, leveraging state-of-the-art processes. Learn more about our services.
Go to
CCL17/A-152E5.3 products
collection>>
(antibodies,
antigen, VLP, mRNA, ORF viral vector, etc)
Catalog No. | Product Name | lentivirus Grade | lentivirus quantity |
---|---|---|---|
vGMLP004761 | Human CCL17 Lentivirus particle | Pilot Grade | 1.0E+8TU |
5.0E+8TU | |||
1.0E+9TU | |||
Research Grade | 1.0E+8TU | ||
5.0E+8TU | |||
1.0E+9TU | |||
GMP-like Grade | inquiry | ||
GMP Grade | inquiry |
Product Description
Catalog ID | vGMLP004761 |
Gene Name | CCL17 |
Accession Number | NM_002987 |
Gene ID | 6361 |
Species | Human |
Product Type | Lentivirus particle (overexpression) |
Insert Length | 285 bp |
Gene Alias | A-152E5.3,ABCD-2,SCYA17,TARC |
Fluorescent Reporter | ZsGreen |
Mammalian Cell Selection | Puromyocin |
Fusion Tag | 3xflag (C-Terminal) |
Promoter | CMV |
Resistance | Amplicin |
ORF Nucleotide Sequence | ATGGCCCCACTGAAGATGCTGGCCCTGGTCACCCTCCTCCTGGGGGCTTCTCTGCAGCACATCCACGCAGCTCGAGGGACCAATGTGGGCCGGGAGTGCTGCCTGGAGTACTTCAAGGGAGCCATTCCCCTTAGAAAGCTGAAGACGTGGTACCAGACATCTGAGGACTGCTCCAGGGATGCCATCGTTTTTGTAACTGTGCAGGGCAGGGCCATCTGTTCGGACCCCAACAACAAGAGAGTGAAGAATGCAGTTAAATACCTGCAAAGCCTTGAGAGGTCTTGA |
ORF Protein Sequence | MAPLKMLALVTLLLGASLQHIHAARGTNVGRECCLEYFKGAIPLRKLKTWYQTSEDCSRDAIVFVTVQGRAICSDPNNKRVKNAVKYLQSLERS |
Reference
Data / case study
Click to get more Data / Case study about the product.
Associated products
Category | Cat No. | Products Name |
---|---|---|
Target Antibody | GM-Tg-g-SE0742-Ab | Anti-CCL17/ A-152E5.3/ ABCD-2 functional antibody |
Target Antigen | GM-Tg-g-SE0742-Ag | CCL17 protein |
Cytokine | cks-Tg-g-GM-SE0742 | chemokine (C-C motif) ligand 17 (CCL17) protein & antibody |
ORF Viral Vector | pGMLP004761 | Human CCL17 Lentivirus plasmid |
ORF Viral Vector | vGMLP004761 | Human CCL17 Lentivirus particle |
Target information
Target ID | GM-SE0742 |
Target Name | CCL17 |
Gene Group Identifier (Target Gene ID in Homo species) |
6361 |
Gene ID |
100140488 (Bos taurus), 100630824 (Equus caballus), 117518 (Rattus norvegicus), 20295 (Mus musculus) 403586 (Canis lupus familiaris), 493832 (Felis catus), 574180 (Macaca mulatta), 6361 (Homo sapiens) |
Gene Symbols & Synonyms | CCL17,Ccl17,Tarc,Scya17,Abcd-2,Scya17l,TARC,ABCD-2,SCYA17,A-152E5.3 |
Target Alternative Names | CCL17,C-C motif chemokine 17,CC chemokine TARC, Small-inducible cytokine A17, Thymus and activation-regulated chemokine,TARC,ABCD-2,SCYA17,A-152E5.3 |
Uniprot Accession |
Q8HYP9,Q8I021,Q92583,Q95N01,Q9ERE0,Q9WUZ6
Additional SwissProt Accessions: Q9ERE0,Q9WUZ6,Q95N01,Q8I021,Q8HYP9,Q92583 |
Uniprot Entry Name | |
Protein Sub-location | Secreted Protein/Potential Cytokines |
Category | Cytokine Target |
Disease | cancer, Breast Cancer, Overactive bladder |
Disease from KEGG | Cytokine-cytokine receptor interaction, Viral protein interaction with cytokine and cytokine receptor, Chemokine signaling pathway, C-type lectin receptor signaling pathway, IL-17 signaling pathway |
Gene Ensembl | ENSBTAG00000066638, ENSMUSG00000031780, ENSCAFG00845003329, ENSMMUG00000058419, ENSG00000102970 |
Target Classification |
About GMVC
GMVC (GM Vector Core) is GeneMedi’s unique platform for QbD Viral vectors Processes development and manufacturing. In GMVC, our core expertise lies in the tailored production of viral vectors, including adeno-associated virus (AAV), lentivirus, and adenovirus. Our state-of-the-art facilities are equipped for scalable manufacturing, ensuring high-quality viral vector production to meet both research and therapeutic needs. Our expert team specializes in process development, leveraging innovative technology and extensive industry knowledge to provide clients with tailored solutions that exceed expectations. GMVC will be the ideal partner for scientists and healthcare professionals seeking reliable and efficient viral vector production services.